データなし
データなし
Gyre Therapeutics Entered Into Open Market Sale Agreement, May Offer & Sell Shares Of Common Stock Of Up To $50M From Time To Time
Gyre Therapeutics Shares Are Trading Lower After the Company Reported a Year-over-year Decline in Q3 Financial Results.
ジャイヤ・セラピュ―ティクス | 8-K:Gyre Therapeuticsは、2024年第3四半期と年初来の財務結果を報告し、ビジネスアップデートを提供します
Earnings Flash (GYRE) GYRE THERAPEUTICS Posts Q3 Revenue $25.5M
Public Companies Among Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 6.9% Last Week
Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) Market Cap Dropped US$51m Last Week; Public Companies Bore the Brunt
データなし